Coustan-Smith E - Search Results

1

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

Rubnitz JE, Inaba H, Dahl G, Ribeiro RC, Bowman WP, Taub J, Pounds S, Razzouk BI, Lacayo NJ, Cao X, Meshinchi S, Degar B, Airewele G, Raimondi SC, Onciu M, Coustan-Smith E, Downing JR, Leung W, Pui CH, Campana D. Rubnitz JE, et al. Lancet Oncol. 2010 Jun;11(6):543-52. doi: 10.1016/S1470-2045(10)70090-5. Epub 2010 May 5. Lancet Oncol. 2010. PMID: 20451454 Free PMC article. Clinical Trial.

2

Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia.

Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D. Manabe A, et al. Blood. 1992 May 1;79(9):2370-7. Blood. 1992. PMID: 1373973 Free article.

3

The definition of remission in acute leukemia with immunologic techniques.

Campana D, Coustan-Smith E, Behm FG. Campana D, et al. Bone Marrow Transplant. 1991 Dec;8(6):429-37. Bone Marrow Transplant. 1991. PMID: 1790423 Review.

4

The immunologic detection of minimal residual disease in acute leukemia.

Campana D, Coustan-Smith E, Janossy G. Campana D, et al. Blood. 1990 Jul 1;76(1):163-71. Blood. 1990. PMID: 1973061 Free article.

5

Immunophenotyping in haematological diagnosis.

Campana D, Coustan-Smith E, Janossy G. Campana D, et al. Baillieres Clin Haematol. 1990 Oct;3(4):889-919. doi: 10.1016/s0950-3536(05)80140-4. Baillieres Clin Haematol. 1990. PMID: 2271795 Review. No abstract available.

6

Phenotypic, genotypic, cytochemical, and ultrastructural characterization of acute undifferentiated leukemia.

Campana D, Hansen-Hagge TE, Matutes E, Coustan-Smith E, Yokota S, Shetty V, Bartram CR, Janossy G. Campana D, et al. Leukemia. 1990 Sep;4(9):620-4. Leukemia. 1990. PMID: 2395382

7

The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.

Janossy G, Coustan-Smith E, Campana D. Janossy G, et al. Leukemia. 1989 Mar;3(3):170-81. Leukemia. 1989. PMID: 2465463

8

Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells.

Manabe A, Murti KG, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Campana D. Manabe A, et al. Blood. 1994 Feb 1;83(3):758-66. Blood. 1994. PMID: 7507732 Free article.

9

XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.

Koehler M, Hurwitz CA, Krance RA, Coustan-Smith E, Williams LL, Santana V, Ribeiro RC, Brenner MK, Heslop HE. Koehler M, et al. Bone Marrow Transplant. 1994 May;13(5):571-5. Bone Marrow Transplant. 1994. PMID: 7519937

10

N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia.

Coustan-Smith E, Behm FG, Hurwitz CA, Rivera GK, Campana D. Coustan-Smith E, et al. Leukemia. 1993 Jun;7(6):853-8. Leukemia. 1993. PMID: 7684798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page